REGENXBIO Inc. (RGNX) Earnings
NASDAQ·Healthcare·Biotechnology
$10.34
+3.82%
Mkt Cap $500.95M
EPS — Estimate vs Actual
Mkt Cap
$500.95M
P/E
—
Fwd P/E
—
P/S
5.70
Rev TTM
—
EPS TTM
-$5.60
NASDAQ·Healthcare·Biotechnology
$10.34
+3.82%
Mkt Cap $500.95M
Mkt Cap
$500.95M
P/E
—
Fwd P/E
—
P/S
5.70
Rev TTM
—
EPS TTM
-$5.60